185 related articles for article (PubMed ID: 37592001)
1. The impact of race on survival in metastatic prostate cancer: a systematic literature review.
Freedland SJ; Samjoo IA; Rosta E; Lansing A; Worthington E; Niyazov A; Nazari J; Arondekar B
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):461-474. PubMed ID: 37592001
[TBL] [Abstract][Full Text] [Related]
2. Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer.
Bernard B; Muralidhar V; Chen YH; Sridhar SS; Mitchell EP; Pettaway CA; Carducci MA; Nguyen PL; Sweeney CJ
Cancer; 2017 May; 123(9):1536-1544. PubMed ID: 28055108
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis.
Vince RA; Jiang R; Bank M; Quarles J; Patel M; Sun Y; Hartman H; Zaorsky NG; Jia A; Shoag J; Dess RT; Mahal BA; Stensland K; Eyrich NW; Seymore M; Takele R; Morgan TM; Schipper M; Spratt DE
JAMA Netw Open; 2023 Jan; 6(1):e2250416. PubMed ID: 36630135
[TBL] [Abstract][Full Text] [Related]
4. Racial/Ethnic Disparities in the Performance of Prediction Models for Death by Suicide After Mental Health Visits.
Coley RY; Johnson E; Simon GE; Cruz M; Shortreed SM
JAMA Psychiatry; 2021 Jul; 78(7):726-734. PubMed ID: 33909019
[TBL] [Abstract][Full Text] [Related]
5. Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database.
Jani C; Mouchati C; Abdallah N; Mariano M; Jani R; Salciccioli JD; Marshall DC; Singh H; Sheng I; Shalhoub J; McKay RR
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):552-562. PubMed ID: 36522462
[TBL] [Abstract][Full Text] [Related]
6. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract][Full Text] [Related]
7. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).
Cohen JH; Schoenbach VJ; Kaufman JS; Talcott JA; Schenck AP; Peacock S; Symons M; Amamoo MA; Carpenter WR; Godley PA
Cancer Causes Control; 2006 Aug; 17(6):803-11. PubMed ID: 16783608
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment.
Slezak JM; Van Den Eeden SK; Cannavale KL; Chien GW; Jacobsen SJ; Chao CR
Cancer Med; 2020 Nov; 9(22):8530-8539. PubMed ID: 32965775
[TBL] [Abstract][Full Text] [Related]
10. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.
Kadan-Lottick NS; Ness KK; Bhatia S; Gurney JG
JAMA; 2003 Oct; 290(15):2008-14. PubMed ID: 14559954
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.
Ma TM; Romero T; Nickols NG; Rettig MB; Garraway IP; Roach M; Michalski JM; Pisansky TM; Lee WR; Jones CU; Rosenthal SA; Wang C; Hartman H; Nguyen PL; Feng FY; Boutros PC; Saigal C; Chamie K; Jackson WC; Morgan TM; Mehra R; Salami SS; Vince R; Schaeffer EM; Mahal BA; Dess RT; Steinberg ML; Elashoff D; Sandler HM; Spratt DE; Kishan AU
JAMA Netw Open; 2021 Dec; 4(12):e2139769. PubMed ID: 34964855
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer disparities among American Indians and Alaskan Natives in the United States.
Chu CE; Leapman MS; Zhao S; Cowan JE; Washington SL; Cooperberg MR
J Natl Cancer Inst; 2023 Apr; 115(4):413-420. PubMed ID: 36629492
[TBL] [Abstract][Full Text] [Related]
13. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
14. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
[TBL] [Abstract][Full Text] [Related]
15. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening.
Chen T; Kharazmi E; Fallah M
JAMA Netw Open; 2023 Apr; 6(4):e238893. PubMed ID: 37074714
[TBL] [Abstract][Full Text] [Related]
16. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
19. Trends in prostate cancer mortality among black men and white men in the United States.
Chu KC; Tarone RE; Freeman HP
Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
[TBL] [Abstract][Full Text] [Related]
20. Association Between Prostate-Specific Antigen Screening and Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White US Veterans.
Sherer MV; Qiao EM; Kotha NV; Qian AS; Rose BS
JAMA Oncol; 2022 Oct; 8(10):1471-1476. PubMed ID: 35925581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
